Actuate Therapeutics, Inc. – Filings and Transcripts

NASDAQ: ACTU
Share price (11/6/26): $0.33
Market cap (11/6/26): $18.1 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Initial registration of new securities – amended

Initial registration of new securities – amended

Free writing prospectus

Initial registration of new securities

Ownership Filter

Demetriades James T, Thomson Todd S, Kairos Venture Partners II, L.P., Kairos Venture Opportunities I, L.P., Kairos SPV Fund LLC, Kairos-Actuate SPV, L.P., Kairos Venture Investments, LLC

BIOS Fund III NT, LP, BIOS Fund III QP, LP, BIOS Fund III, LP

Hexstone Capital LLC

BIOS Fund I, LP, BIOS Fund I QP, LP, BIOS Fund II, LP, BIOS Fund II QP, LP, BIOS Fund II NT, LP, BIOS Actuate Co-Invest I, LP, BIOS Actuate Co-Invest II, LP, Bios Actuate Co-Invest III, LP, Bios Clinical Opportunity Fund, LP, Bios 2024 Co-Invest, LP

Schmitt Daniel M

News Filter

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Announces Pricing of $11.0 Million Underwritten Public Offering

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Shareholder Vote Results

Announces FDA Clearance of IND for Oral Elraglusib and Strategic Initiatives to Advance the Elraglusib Development Program

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC